Naruhiko Ikoma, MD, MS

Assistant Professor of Surgical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Naruhiko Ikoma, M.D. M.S. is a surgical oncologist specializing in minimally-invasive surgery (robotic surgery) and multidisciplinary therapy on pancreas cancer and gastric cancer, at The University of Texas MD Anderson Cancer Center, Houston, Texas. He completed fellowships in Surgical Oncology at MD Anderson Cancer Center and Keio University School of Medicine (Tokyo, Japan), and is Board Certified both in the United States and Japan.

Presentation(s):

• SSO 2024 Robotics Pre-Meeting- Advanced Robotic Surgery Workshop in Complex HPB/UGI

  Wednesday, March 20, 2024
  7:00am – 4:00pm ET

• 71: Phase I Trial of Intraperitoneal Paclitaxel in Patients with Gastric Adenocarcinoma and Peritoneal Carcinomatosis or Positive Peritoneal Cytology

  Thursday, March 21, 2024
  2:22pm – 2:32pm ET

• Novel Surgical Options for UGI Cancers

  Thursday, March 21, 2024
  4:02pm – 4:12pm ET

• 89: Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy

  Friday, March 22, 2024
  10:32am – 10:42am ET

• 92: Phase I Trial of Short-Course Chemoradiotherapy followed by Chemotherapy as Total Neoadjuvant Therapy for Patients with Potentially Resectable Gastric Cancer

  Friday, March 22, 2024
  11:02am – 11:12am ET

• P37: CA 19-9 Normalization Following Neoadjuvant Therapy and Yield of Laparoscopy for Pancreatic Ductal Adenocarcinoma

  Friday, March 22, 2024
  2:04pm – 2:10pm ET